GSK Hepatitis B vaccine availability
18 August 2017
We are currently experiencing a supply constraint of Twinrix Adult (combined hepatitis A and B vaccine) due to a precautionary disruption in the manufacturing process.
Twinrix Junior (combined hepatitis A and hepatitis B vaccine) continues to be available and is not impacted by this supply constraint.
We understand that this stock out may be distressing for those who are not covered by government programs and who may be required to vaccinate themselves for occupational reasons or because they are planning on travelling to hepatitis-affected areas.
At this stage, we expect to provide the next update in early November 2017.
GSK is currently experiencing an on-going supply constraint of Engerix-B® Adult dose (hepatitis B surface antigen recombinant (yeast) vaccine) in Australia. Production is now back to normal however, it will take time to re-build capacity.
At this stage we are unable to confirm a re-supply date.
We are currently experiencing an intermittent supply constraint of Engerix-B® paediatric dose for the private market. We expect to return to supply by the end of 2017.
Supply of GSK vaccines containing hepatitis B to Government programs is not impacted.
Please visit the TGA website for ongoing updates to supply.
For more information, please contact GSK medical information on 1800 033 109.